Elderly patient

UHP and UCL to collaborate in clinical trial for Parkinson’s treatment

An Honorary Consultant Neurologist at University Hospitals Plymouth NHS Trust (UHP), is now able to co-lead the Accelerating Clinical Treatments for Parkinson’s Disease project, following a £1.375m grant from the charity, Edmond J. Safra Foundation.

This will involve establishing a multi-arm multi-stage clinical trial platform, where potential protective therapies will be quickly assessed. These therapies will be those aimed at either slowing down or stopping the progression of Parkinson’s.

At the early stage of trailing prospective therapies, they will be quickly removed and replaced if they are shown to be ineffective. This platform will allow 12 drugs to be initiated in a trial over five years. Previously this would have taken 40 years and ten times as many patients, using established protocols.

The project will be co-led by Professors Thomas Foltynie and Sonia Gandhi at the University College London’s (UCL) Movement Disorders Centre, and Dr Camille Carroll at UHP, and carried out in partnership with the Medical Research Council Clinical Trials Unit at UCL.

Dr Camille Carroll, Honorary Consultant Neurologist at UHP, Associate Professor at the University of Plymouth, and NIHR Specialty Lead for Neurodegenerative Diseases, said: “The funding provided by the Edmond J. Safra Foundation will enable a sea of change in how we investigate therapies that could slow or stop Parkinson’s progression. We are very pleased to be partnering with colleagues at UCL to realise the vision of developing this trial platform for Parkinson’s.

“The UK is the right place to deliver this ambitious, world-leading project, which we hope will herald the beginning of the end of Parkinson’s.”

Current treatments are only able to alleviate symptoms, but are unable to alter the course of the disease. This is viewed as being a new approach to clinical trial design, aiming to tackle inefficiencies in “conventional” trial models, enabling multiple drugs to be tested simultaneously, and seamlessly transitioned from early to later stage clinical testing.

Professor Thomas Foltynie, Professor of Neurology in the Department of Clinical and Movement Neurosciences at UCL, said: “We are delighted to embark on this project with the support of the Edmond J. Safra Foundation. Our existing process of ‘one drug at a time’ is far too inefficient, and it is high time that we had a platform capable of assessing multiple approaches simultaneously.

“This project will revolutionise the way we perform clinical trials of potentially disease-modifying drugs for people with Parkinson’s.”

Mrs Lily Safra, Chairwoman of the Edmond J. Safra Foundation, said: “I am so incredibly proud to be able to offer our support to those undertaking visionary research at UCL and the University of Plymouth. I have witnessed first-hand the effects that Parkinson’s has on patients and their loved ones, and I feel great hope and excitement at the prospect of the Edmond J. Safra ACT-PD Initiative identifying the treatments which hold the promise of a brighter future.”

The charity has shown a significant amount of support for Parkinson's research and patient care at many worldwide hospitals and institutes. The project will run until 2023 and will also be supported by the NIHR, providing expertise in trial development and provision of trial delivery infrastructure across UK healthcare. During this time, the project team will design the trial platform.

Jan/Feb

NHE January/February 2024

Boosting NHS productivity demands a healthy dose of realism

Dive into our latest edition for January/February!

Videos...

View all videos
Online Conference

Presenting

2024 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Ep 41. The truth about drones in the NHS

In episode 41 of the National Health Executive podcast, we were joined by Dr Angela Smith, research fellow at Bournemouth University, and Andy Oakey, research fellow at the University of Southampton, to discuss the viability of drones within the NHS transport system.

More articles...

View all